Clinical Trial Update: Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients [NA]

View source ↗

Summary

A randomized trial comparing Arixtra to Lovenox for preventing blood clots in medically ill patients was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thrombosis

Drugs mentioned

• ARIXTRA (fondaparinux sodium)
• Lovenox (enoxaparin)

Snippet

Sponsor: Lehigh Valley Hospital | Conditions: Venous Thrombosis | NA | Status: TERMINATED | Results posted: 2017-11-01